Skip to content
drillr.ai

AXSM

Axsome Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$229.99-0.00%

Price as of Jul 20, 2026

AXSM ownership

Axsome Therapeutics, Inc. ownership & insider activity

Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
11
Net (3m)
-$37.2M
Insider trades by month Buys Sells
Jan
Feb
Apr
May
Jun
Jul
Context3-month price +27.7%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jul 1, 2026TABUTEAU HERRIOTdirector, 10 percent owner, officer: Chief Executive OfficerSell49,666$240.25
Jul 1, 2026TABUTEAU HERRIOTdirector, 10 percent owner, officer: Chief Executive OfficerOption49,666$4.95
Jun 11, 2026JEFFS ROGERdirectorSell286$246.18
Jun 10, 2026JEFFS ROGERdirectorOption1,429—
Jun 10, 2026Coleman MarkdirectorSell643$249.00
Jun 10, 2026Mahony SusandirectorOption1,429—
Jun 10, 2026Mahony SusandirectorSell300$237.21
Jun 10, 2026Coleman MarkdirectorOption1,429—
Jun 10, 2026Saad Mark EdirectorOption1,429—
Jun 9, 2026JEFFS ROGERdirectorGrant1,721—
Jun 9, 2026Coleman MarkdirectorGrant1,721—
Jun 9, 2026Mahony SusandirectorGrant1,721—
Jun 9, 2026TABUTEAU HERRIOTdirector, 10 percent owner, officer: Chief Executive OfficerOption49,670$4.95
Jun 9, 2026TABUTEAU HERRIOTdirector, 10 percent owner, officer: Chief Executive OfficerSell49,670$241.01
Jun 9, 2026Pizzie Nickofficer: Chief Financial OfficerOption33,000$3.50
Jun 9, 2026Pizzie Nickofficer: Chief Financial OfficerSell33,000$240.09
Jun 9, 2026Saad Mark EdirectorGrant1,721—
Jun 2, 2026Coleman MarkdirectorSell6,000$233.46
Jun 2, 2026Coleman MarkdirectorSell5,537$223.39
May 5, 2026Jacobson Mark L.officer: Chief Operating OfficerOption233$12.95
May 5, 2026Jacobson Mark L.officer: Chief Operating OfficerSell233$228.18
May 5, 2026Jacobson Mark L.officer: Chief Operating OfficerSell4,517$227.94
May 5, 2026Jacobson Mark L.officer: Chief Operating OfficerOption4,517$12.95
Apr 23, 2026Pizzie Nickofficer: Chief Financial OfficerGrant8,188—
Apr 23, 2026Murdock Hunter R.officer: General CounselGrant7,224—
Apr 23, 2026Jacobson Mark L.officer: Chief Operating OfficerGrant8,669—
Apr 23, 2026TABUTEAU HERRIOTdirector, 10 percent owner, officer: Chief Executive OfficerGrant24,081—
Apr 23, 2026Maizel Ariofficer: Chief Commercial OfficerOption7,500$70.73
Apr 23, 2026Maizel Ariofficer: Chief Commercial OfficerSell7,500$182.42
Apr 23, 2026Maizel Ariofficer: Chief Commercial OfficerGrant7,224—

Source: AXSM SEC Form 4 filings, latest Jul 1, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their AXSM positions over the last 6 months (SEC Form 13F).

Increased
295
New positions
161
Reduced
271
Sold out
97
Largest moves
InstitutionActionSharesFiled
VANGUARD GROUP INCReduced4.2MJan 29, 2026
BLACKROCK, INC.Increased3.9MFeb 12, 2026
BLACKROCK, INC.Reduced3.9MMay 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position2.1MMay 8, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1.9MMay 15, 2026
FMR LLCIncreased1.6MMay 15, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased1.5MFeb 17, 2026
PRICE T ROWE ASSOCIATES INC /MD/Reduced1.3MMay 15, 2026
INVESCO LTD.Increased1.3MMay 12, 2026
INVESCO LTD.Increased1.3MFeb 19, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced1.2MFeb 17, 2026
FMR LLCIncreased1.2MFeb 17, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased1.2MMay 15, 2026
DEEP TRACK CAPITAL, LPIncreased1.1MFeb 13, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced1.1MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.